Edge Therapeutics, Inc.

Edge Therapeutics is a clinical-stage biopharmaceutical company focused on developing and commercializing life-saving hospital products that improve patient outcome by addressing acute, fatal or debilitating conditions that have no current effective treatment. These delayed complications occur days to weeks after different types of brain hemorrhages (ruptured brain aneurysms, chronic subdural hematoma, subarachnoid and intracerebral hemorrhage and head trauma).

Scroll to Top